Home Administrative Billing & Reimbursement BlueCard® Health and Wellness Medical PEAR portal Pharmacy Products Quality Management

National Drug Code submission guidelines for co-packaged products listed as kits and multi-level packaged products

June 25, 2019

The U.S. Food and Drug Administration (FDA) guidelines for National Drug Code (NDC) submissions for co-packaged products listed as kits and multi-level packaged products are as follows:

For co-packaged products listed as kits and multi-level packaged products, providers should report the NDC on the OUTERMOST package. Only the outermost NDC is reported by firms as part of their product listing submission to the FDA and included in the NDC directory. Only NDCs included in the NDC directory will be considered valid NDCs for claims submission.

Resources

Additional information is available on the FDA’s NDC Package File Definitions webpage and on our dedicated NDC webpage.

The NDC submission guidelines for co-packaged products listed as kits and multi-level packaged products will be added to the Billing section of the Provider Manual for Participating Professional Providers and the Billing & Reimbursement for Ancillary Services section of the Hospital Manual for Participating Hospitals, Ancillary Facilities, and Ancillary Providers.


This content was prepared for the Provider News Center and may not be reproduced in any way without the express written permission of Independence Blue Cross. Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association.
Connect with us     Facebook     Twitter     Flickr     YouTube     Walk the Talk    Independence Pinterest    Independence LinkedIn    Independence Instagram Site Map        Anti-Fraud        Privacy Policy        Legal        Disclaimer
© 2023 Independence Blue Cross.
Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association, serving the health insurance needs of Philadelphia and southeastern Pennsylvania.